Précédent|Prochain

Discussion méthodologique sur la prescription pour l'agrégation des nouvelles ressources médicinales

  • role： First author第一作者
  • Affiliation：

    School of Traditional Chinese Medicine， Shandong University of Traditional Chinese Medicine， Jinan 250355， China

    Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs， Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences， Beijing 100700， China

  • Email：mingwenhua0606@163.com
  • Introduction：明文华，在读硕士，从事方剂配伍规律数据挖掘及临床应用研究，E-mail：mingwenhua0606@163.com
MING Wenhua12,  
  • Affiliation：

    School of Traditional Chinese Medicine， Shandong University of Traditional Chinese Medicine， Jinan 250355， China

LI Qingqing1,  
  • Affiliation：

    Experimental Research Center， China Academy of Chinese Medical Sciences， Beijing 100700， China

LI Caifeng3,  
  • Affiliation：

    China Institute for History of Medicine and Medical Literature， China Academy of Chinese Medical Sciences， Beijing 100700， China

WANG Yeran4,  
  • Affiliation：

    Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs， Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences， Beijing 100700， China

WANG Lan2,  
  • Affiliation：

    Institute of Information on Traditional Chinese Medicine， China Academy of Chinese Medicinal Sciences， Beijing 100700， China

LI Yanwen5,  
  • role： Corresponding author通信作者
  • Affiliation：

    Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs， Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences， Beijing 100700， China

  • Email：lizhiyong7899@sina.com
  • Introduction：李志勇，研究员，从事外来新药用资源的引进与开发，E-mail：lizhiyong7899@sina.com
LI Zhiyong2*

résumé

La médecine traditionnelle chinoise est la base matérielle de la culture médicale chinoise dans notre pays, et l'utilisation durable des ressources médicinales chinoises est un point important dans la réalisation de la modernisation de la médecine traditionnelle chinoise. Les ressources traditionnelles de la médecine chinoise sont de plus en plus rares, et l'extension de nouvelles ressources médicinales chinoises devient un moyen important d'utiliser durablement les ressources médicales chinoises. Les nouvelles ressources médicinales chinoises se réfèrent à des ressources naturelles ayant une valeur médicinale potentielle ou une fonction de santé, récemment découvertes ou développées en dehors de l'utilisation traditionnelle de plantes médicinales, qui ne sont pas encore largement connues ou appliquées selon la théorie traditionnelle de la médecine chinoise, y compris les ressources médicinales artificielles remplaçant les médicaments chinois en voie de disparition, les nouvelles parties médicinales de plantes, les ressources élargies en pratique clinique des médicaments et les ressources médicinales étrangères. La distribution rationnelle et la composition des nouvelles ressources médicinales chinoises sont un moyen important de les intégrer dans le système de médecine chinoise. En raison de la faiblesse relative de la recherche fondamentale sur les nouvelles ressources médicinales chinoises dans notre pays, et de l'imperfection des caractéristiques des médicaments chinois selon la théorie traditionnelle de la médecine chinoise, il existe de nombreux facteurs limitants pour intégrer les nouvelles ressources médicinales chinoises dans le système de médecine chinoise selon les principes traditionnels de prescription. Cet article combine la théorie de la prescription de la médecine chinoise traditionnelle et la méthode moderne d'agrégation des données, proposant quatre modèles de prescription pour les nouvelles ressources médicinales chinoises : une combinaison coordonnée, une combinaison alternative, une combinaison avec preuve et une combinaison sémantique des effets, offrant de nouvelles idées pour l'application des nouvelles ressources médicinales chinoises, non seulement pour promouvoir une utilisation rationnelle des nouvelles ressources médicinales chinoises dans la pratique clinique, mais aussi pour fournir un soutien théorique au développement et à la recherche sur la prescription de nouvelles ressources médicinales chinoises.

mots-clés

Nouvelles ressources médicinales; stratégies de prescription; règles de coordination

References

  1. 1.
    HUANG L Q，PENG H S，XIAO P G.Development trend of traditional Chinese medicine resources［J］.China J Chin Mater Med，2011，36（1）：1-4.
  2. 2.
    State Administration for Market Regulation.Administrative measures for drug registration［EB/OL］.（2020-01-22）［2025-01-03］..
  3. 3.
    DAI Y，ZHANG Y G，ZENG J，et al.Mystery of Yiyin decoction theory： Rule discovery and evaluation strategy of atypical pharmacological effects of Chinese medicinal prescription［J］.China J Chin Mater Med，2022，47（16）：4261-4268.
  4. 4.
    BAI J Q，LIN Q Q，HUANG L Q.Preliminary discussion on silk road with Chinese traditional medicine［J］.Mod Chin Med，2016，18（6）：793-797.
  5. 5.
    LIU Y，XIAO W，QIAO J，et al.Chinese materia medica and OBAOR［J］.Mod Chin Med，2015，17（2）：91-93.
  6. 6.
    DING L W.The conservation of endangered and rare traditional Chinese medicinal resources is of urgent necessity.［J］.Mod Chin Med，2010，12（4）：47-49.
  7. 7.
    WU X C，JIA X B，MA W K，et al.Research on artificial substitutes of rare and endangered animal medicinal materials and industrialization［J］.China J Chin Mater Med，2022，47（23）：6278-6286.
  8. 8.
    QU L P， TANG J Y，ZHANG L，et al.Category of Chinese medicine registration：Historical evolution，current status，andproblems［J］.China J Chin Mater Med，2022，47（2）：562-568.
  9. 9.
    XIAO F，LIU X L，LI Y Z，et al.The current status and substitution approaches of endangered traditional Chinese medicinal materials［J］.Her Med，2014，33（7）：973-975.
  10. 10.
    China Medicine Education Association.Experts consensus on clinical application of Angong Niuhuang pill［J］.Chin J Integr Tradit West Med，2022，42（8）：933-946.
  11. 11.
    ZHONG X M，REN X C，LOU Y L，et al.Effects of in vitro cultured calculus bovis on learning and memory impairments of hyperlipemia vascular dementia rats［J］.J Ethnopharmacol，2016，192：390-397.
  12. 12.
    WANG J，XING H，QIN X，et al.Pharmacological effects and mechanisms of muscone［J］.J Ethnopharmacol， 2020，262：113120.
  13. 13.
    LIU R，TANG J，WU W，et al.Combination of mathematics and label-free proteomics for discovering keratin-derived specific peptide biomarkers to distinguish animal horn-derived traditional Chinese medicines［J］.J Sep Sci，2023，46（9）：e2200949.
  14. 14.
    HUANG M R，ZHAO W J， LI J S，et al.Research advance of chemical constituents，analytical methods and pharmacological effects of cow-bezoar and its substitutes［J］.Chin J Pharmaceut Analysis，2018，38（7）：1116-1123.
  15. 15.
    LV S，LEI Z，YAN G，et al.Chemical compositions and pharmacological activities of natural musk （Moschus） and artificial musk：A review［J］.J Ethnopharmacol，2022，284：114799.
  16. 16.
    LIN N，ZHONG L L，LI N，et al.The study on the anti-fatigue effects of Ginseng flower extract［J］.J Changchun Univ Chin Med，2010，26（3）：336-337.
  17. 17.
    CHEN L X，QI Y L，QI Z，et al.A comparative study on the effects of different parts of Panax ginseng on the immune activity of cyclophosphamide-induced immunosuppressed mice［J］.Molecules，2019，24（6）：336-337.
  18. 18.
    Editorial Group of Zhonghua Bencao. Zhonghua Bencao［M］.5 edition.Shanghai：Shanghai Scientific and Technical Publishers，1999：830-831.
  19. 19.
    YANG H J，YANG S H，PANG L J.Research progress of ginseng flower buds［J］.Ginseng Res，2013，25（1）：56-57.
  20. 20.
    SONG L，WANG Y，ZHANG Z，et al.Study on compatibility of ginseng flower with Astragalus and Liriope［J］.Chin J Pharm Anal，2013，33（12）：2114-2118.
  21. 21.
    YANG Y，ZHOU B，ZHAO W J.Ginkgo biloba leaves history：A model of research and development for Chinese materia medica/phytomedicine［J］.Chin Tradit Herbal Drugs，2016，47（15）：2579-2591.
  22. 22.
    BIERNACKA P，ADAMSKA I，FELISIAK K.The potential of Ginkgo biloba as a source of biologically active compounds-A review of the recent literature and patents［J］.Molecules，2023，28（10）：54.
  23. 23.
    Yaozh Data Network［EB/OL］.［2024-10-12］..
  24. 24.
    Chinese Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China 20［M］.Beijing：The Medicine Science and Technology Press of China，2020.
  25. 25.
    LI L S，FENG Z K，LIU D Q.Comprehensive textual research on concept，content and function of Chinese yew［J］.China J Chin Mater Med，2011，36（12）：1682-1685.
  26. 26.
    GALLEGO-JARA J，LOZANO-TEROL G，SOLA-MARTINEZ R A，et al.A compressive review about Taxol（R）：History and future challenges［J］.Molecules，2020，doi：.
  27. 27.
    YANG Y H，MAO J W，TAN X L.Research progress on the source， production，and anti-cancer mechanisms of paclitaxel［J］.Chin J Nat Med，2020，18（12）：890-897.
  28. 28.
    GAO H Q，BU X M，JIANG W，et al.Compound taxus exerts marked anti-tumor activity and radiosensitization effect on hepatocellular carcinoma cells［J］.Heliyon，2024，10（5）：e27345.
  29. 29.
    SONG X.Ancient persian medicine and China［M］.Beijing：Economic Daily Press，2001：73.
  30. 30.
    JIN Y Z，YU Y，FU L，et al.Preliminary study of history of senna be used in China-on phenomenon about "Reignmedicine localized"［J］.China J Chin Mater Med，2016，41（12）：2371-2375.
  31. 31.
    Ministry of Health of the People's Republic of China.Announcement on the approval of four new resource foods including chlorella pyrenoidosa［EB/OL］.（2012-12-13）［2024-10-14］..
  32. 32.
    SHA Z J，LIU Y H，YANG B，et al.Textual research on traditional application of Moringa［J］.China J Chin Mate Med，2020，45（12）：2800-2807.
  33. 33.
    TANG M H，FENG L，FU R，et al.Traditional application and modern research progress on new foreign medicinal resources［J］.China J Chin Mater Med，2023，48（13）：3421-3439.
  34. 34.
    LEI H C.To implement the Party's policy on health and health work in the new era and strive to write a new chapter in building a healthy China［J］.Dang Jian，2025（1）：17-20.
  35. 35.
    CHEN Y，TANG Y Y，YANG L，et al.Advances on toxicity and metabolism of alkaloids from the "toxic" traditional Chinese medicines［J］.Acta Pharm Sin，2023，58（11）：3285-3295.
  36. 36.
    YANG H R，SUN J N，ZHANG G P，et al.Study on the effect and toxicity of Sini decoction formula from the different compatibility prescription［J］.Chin J Exp Tradit Med Form，2013，19（23）：266-269.
  37. 37.
    ZHAO K Z.Preliminary study of the law of classical square compatibility［J］.Hubei J Tradit Chin Med，2014，36（6）：51-52.
  38. 38.
    LIU W P，XIA M H，WANG Q Q.Current situation and development strategy： Theoretical research of classical formula［J］.J Tradit Chin Med，2019，60（11）：901-906.
  39. 39.
    SUN Y M，XU S，XU Y.Clinical syndrome differentiation and treatment strategy of specific disease-specific medicinethrough the combination of classic and current prescription［J］.China J Tradit Chin Med Pharm，2022，37（12）：6895-6898.
  40. 40.
    WANG B C.Discussion on the formula mode based on the integration of Chinese and Western medicine theories［D］.Changsha：Hunan University of Chinese Medicine，2012.
  41. 41.
    HUANG K，ZHANG P，ZHANG Z，et al.Traditional Chinese medicine （TCM） in the treatment of COVID-19 and other viral infections：Efficacies and mechanisms［J］.Pharmacol Ther，2021，225：107843.
  42. 42.
    WANG X B，LU J J.Overview on good pharmacological practice on Chinese medicine research［J］.Mod Tradit Chin Med Mater Med-World Sci Technol，2019，21（9）：1846-1854.
  43. 43.
    ZHANG J Y，MIAO M S.Rethinking on pharmacology of traditional Chinese medicine［J］.Lishizhen Med Mater Med Res，2024，35（5）：1198-1201.
  44. 44.
    PENG C.Pharmacology of Traditional Chinese Medicine ［M］.5th Edition.Beijing：China Press of Traditional Chinese Medicine，2021.
  45. 45.
    WANG J，WANG Y Y，GUO L L，et al.Study of means of formulating prescription based on combination disease with syndrome［J］.China J Chin Mater Med，2009，34（1）：2-5.
  46. 46.
    LUO B C，HE Y R，WEN L X.Discussion on the formulation model of integrating traditional Chinese and western medicine theory［J］.Chin Med Mod Distance Edu China，2020，18（13）：63-65.
  47. 47.
    ZHANG J H，FAN G W，ZHANG H，et al.Development and application of component-based Chinese medicine theory［J］.China J Chin Mater Med，2017，42（21）：4054-4058.
  48. 48.
    CHENG B，LI X Y，LIU K Q，et al.The Clinical application of compound Salvia miltiorrhiza dropping pills is suggested by Chinese experts［J］.Chin J Integrated Tradit Western Med，2017，37（1）：17-22.
  49. 49.
    CAI Q Q，YAN Z Y.Analysis of resources and medical development of exotic Chinese medicine［J］.Chin Tradit Herbal Drugs，2023，54（16）：5442-5450.
  50. 50.
    ZHANG X B，LU D M，HUANG L Q，et al.Discussion on exploitation of foreign traditional Chinese medicine resources based on "the Belt and Road"［J］.China J Chin Mater Med2018，43（7）：1501-1506.
  51. 51.
    ZHU J G，DUAN J A，LI W L，et al.Status and thinking of quality supervision on imported medicinal materials in shortage［J］.China J Chin Mater Med，2018，43（12）：2628-2632.
  52. 52.
    WANG F X，YU H Y，CAO H Y，et al.Clinical application of Danggui couplet medicines in treating lung diseases based on the theory of mutual promotion and mutual assistance［J］.China J Tradit Chin Med Pharm，2021，36（12）：7173-7176.
  53. 53.
    DUAN J A，SU S L，TANG Y P，et al.Modern understanding of the compatibility and combination of traditional Chinese medicine［J］.J Nanjing Univ Tradit Chin Med，2009，25（5）：330-333.
  54. 54.
    LIU M L，ZHANG X Y，DING L，et al.Application and progress of data mining in study of compatibility law of traditional Chinese medicine［J］.China J Chin Mater Med，2021，46（20）：5233-5239.
  55. 55.
    LI Z Y，YANG H J，TANG S H，et al.Study strategies on medicinal properties of foreign medicine introduced to traditional Chinese medicine［J］.China J Chin Mater Med，2019，44（14）：2972-2979.
  56. 56.
    FANG Z，ZHANG M，YI Z，et al.Replacements of rare herbs and simplifications of traditional Chinese medicine formulae based on attribute similarities and pathway enrichment analysis［J］.Evid Based Complement Alternat Med，2013，2013：136732.
  57. 57.
    WU J P，LI Q Q，WANG L，et al.Exploring efficacy and mechanism of saffron floral bioresidues for treatment of hyperuricemia combined with gouty arthritis based on compound compatibility environment［J］.Chin J Exp Tradit Med Form，2024，30（23）：129-140.
  58. 58.
    LAN X，ZHAO J N，ZHANG Y，et al.Overview of mining methods for tacit knowledge in traditional Chinese medicine ［C］.Proceedings of the 2019 Academic Annual Conference of the Deficiency and Geriatrics Committee of the Chinese Association of Integrative Medicine，the Integrative Medicine Branch of the Chinese Geriatrics Society，and the Geriatrics Committee of the Jiangsu Association of Traditional Chinese Medicine.［Publisher Unknown］，2019：311-314.
  59. 59.
    TAZE D，HARTLEY C，MORGAN A W，et al.Developing consensus in histopathology：The role of the Delphi method［J］.Histopathology，2022，81（2）：159-167.
  60. 60.
    ZHANG Y，JI C H，LI Q S，et al.Statistical analysis method of Delphi technique used in clinical practice guideline of traditional Chinese medicine［J］.China J Tradit Chin Med Pharm，2018，33（1）：249-251.
  61. 61.
    GUAN H，DAI G H，GAO W L，et al.Application of Delphi method in clinical research of traditional Chinese medicine：A systematic review［J］.Chin J Evid-Based Med，2021，21（2）：186-190.
  62. 62.
    QIU T，SUN H，WANG H L，et al.Ethnobotanical study of Juenang cultural area in Rangtang county of northwestern Sichuan［J］.China J Chin Mater Med，2020，45（3）：689-696.
  63. 63.
    LI Z Y，WANG J Q，LI C F，et al.Strategies for efficacy and function positioning of new resources of Chinese materia medica［J］.China J Chin Mater Med，2021，46（14）：3455-3464.
  64. 64.
    SELETENG KOSE L，MOTEETEE A，VAN VUUREN S.Ethnobotanical survey of medicinal plants used in the maseru district of lesotho［J］.J Ethnopharmacol，2015，170：184-200.
  65. 65.
    XIANG N，SHI H X，LI X D，et al.Application of questionnaire survey method in the clinical efficacy evaluation study of TCM［J］.Hubei J Tradit Chin Med，2011，33（6）：29-30.
  66. 66.
    REN J G，WANG D Z，LEI L，et al.Preliminary analysis on relationship between traditional efficacy of Chinese medicine and modern pharmacological action［J］.China J Chin Mater Med，2017，42（10）：1979-1983.
  67. 67.
    ZHU Y.Research on automatic discovery of derivation relationship of analogous formulae［D］.Beijing：China Academy of Chinese Medical Sciences，2016.
  68. 68.
    ZHU Y，ZHU L，GAO B，et al.Construction and application of efficacy semantic network of traditional Chinese medicine［J］.China J Tradit Chin Med Pharm，2016，31（5）：1710-1715.
  69. 69.
    CHEN G L，XU S J，ZHOU F S，et al.Exploring the holistic efficacy of traditional Chinese medicine formulas based on the semantic analysis of "Pharmacological nature-efficacy knowledge elements"［J］.Liaoning J Tradit Chin Med，2011，38（7）：1260-1264.
  70. 70.
    ZHANG F R.Study on the efficacy and semantic representationof stroke and the mechanism of Dandeng Tongnao capsule on ischemic stroke［D］.Jinan：Shandong Traditional Chinese Medicine University，2021.
  71. 71.
    TANG S H.SHAO A J，LIN S F，et al.Current status and future prospects of traditional Chinese medicine substitutes［J］.Res Practice Chin Med，2011，25（2）：83-85.
  72. 72.
    RASTOGI S，VERMA R，RAJU R，et al.Unveiling the therapeutic potential and conservation strategies for rare and endangered medicinal plants in traditional Chinese medicine：A comprehensive review［J］.Chin J Appl Physiol，2024，40：e20240024.
  73. 73.
    YAN L L，WANG B，WANG L，et al.Substitution mode of rare and endangered Chinese medicinal materials and research strategy of multi-component replacement［J］.China J Chin Mater Med，2023，48（1）：30-38.

Lire l'article complet

The above content is generated by Large Model Translation. The translated content is for reference only. We do not assume any commercial or legal responsibilty for any consequences arising from the use of our website